173 related articles for article (PubMed ID: 8097968)
1. Non-glucocorticoid steroid analogues (21-aminosteroids) sensitize multidrug resistant cells to vinblastine.
Abraham I; Wolf CL; Sampson KE
Cancer Chemother Pharmacol; 1993; 32(2):116-22. PubMed ID: 8097968
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the azidopine and vinblastine binding site of P-glycoprotein.
Bruggemann EP; Currier SJ; Gottesman MM; Pastan I
J Biol Chem; 1992 Oct; 267(29):21020-6. PubMed ID: 1356986
[TBL] [Abstract][Full Text] [Related]
3. Multidrug-resistant human KB carcinoma cells are highly resistant to the protein phosphatase inhibitors okadaic acid and calyculin A. Analysis of potential mechanisms involved in toxin resistance.
Chambers TC; Raynor RL; Kuo JF
Int J Cancer; 1993 Jan; 53(2):323-7. PubMed ID: 8093882
[TBL] [Abstract][Full Text] [Related]
4. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.
Cornwell MM; Pastan I; Gottesman MM
J Biol Chem; 1987 Feb; 262(5):2166-70. PubMed ID: 2434476
[TBL] [Abstract][Full Text] [Related]
5. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.
Anuchapreeda S; Leechanachai P; Smith MM; Ambudkar SV; Limtrakul PN
Biochem Pharmacol; 2002 Aug; 64(4):573-82. PubMed ID: 12167476
[TBL] [Abstract][Full Text] [Related]
6. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
Tamai I; Safa AR
J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
[TBL] [Abstract][Full Text] [Related]
7. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
Horio M; Lovelace E; Pastan I; Gottesman MM
Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
[TBL] [Abstract][Full Text] [Related]
8. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine.
Beck WT; Cirtain MC; Glover CJ; Felsted RL; Safa AR
Biochem Biophys Res Commun; 1988 Jun; 153(3):959-66. PubMed ID: 2898941
[TBL] [Abstract][Full Text] [Related]
9. Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma.
Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Akiyama S
Biochem Biophys Res Commun; 1990 Jan; 166(1):74-80. PubMed ID: 1967939
[TBL] [Abstract][Full Text] [Related]
10. Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line.
Kamiwatari M; Nagata Y; Kikuchi H; Yoshimura A; Sumizawa T; Shudo N; Sakoda R; Seto K; Akiyama S
Cancer Res; 1989 Jun; 49(12):3190-5. PubMed ID: 2566378
[TBL] [Abstract][Full Text] [Related]
11. Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labeling of P-glycoprotein.
Nogae I; Kohno K; Kikuchi J; Kuwano M; Akiyama S; Kiue A; Suzuki K; Yoshida Y; Cornwell MM; Pastan I
Biochem Pharmacol; 1989 Feb; 38(3):519-27. PubMed ID: 2563655
[TBL] [Abstract][Full Text] [Related]
12. Aspergillus species strain M39 produces two naphtho-gamma-pyrones that reverse drug resistance in human KB cells.
Ikeda S; Sugita M; Yoshimura A; Sumizawa T; Douzono H; Nagata Y; Akiyama S
Int J Cancer; 1990 Mar; 45(3):508-13. PubMed ID: 1968438
[TBL] [Abstract][Full Text] [Related]
13. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder.
Chearwae W; Anuchapreeda S; Nandigama K; Ambudkar SV; Limtrakul P
Biochem Pharmacol; 2004 Nov; 68(10):2043-52. PubMed ID: 15476675
[TBL] [Abstract][Full Text] [Related]
14. Photoaffinity probes for the alpha 1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein.
Greenberger LM; Yang CP; Gindin E; Horwitz SB
J Biol Chem; 1990 Mar; 265(8):4394-401. PubMed ID: 1968459
[TBL] [Abstract][Full Text] [Related]
15. Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance.
Zordan-Nudo T; Ling V; Liu Z; Georges E
Cancer Res; 1993 Dec; 53(24):5994-6000. PubMed ID: 7903200
[TBL] [Abstract][Full Text] [Related]
16. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
Safa AR; Agresti M; Bryk D; Tamai I
Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells.
Chambers TC; McAvoy EM; Jacobs JW; Eilon G
J Biol Chem; 1990 May; 265(13):7679-86. PubMed ID: 1970571
[TBL] [Abstract][Full Text] [Related]
18. Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells.
Chen AY; Yu C; Potmesil M; Wall ME; Wani MC; Liu LF
Cancer Res; 1991 Nov; 51(22):6039-44. PubMed ID: 1682041
[TBL] [Abstract][Full Text] [Related]
19. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus.
Yang CP; DePinho SG; Greenberger LM; Arceci RJ; Horwitz SB
J Biol Chem; 1989 Jan; 264(2):782-8. PubMed ID: 2562956
[TBL] [Abstract][Full Text] [Related]
20. BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
Liu Z; Lheureux F; Pouliot JF; Heckel A; Bamberger U; Georges E
Mol Pharmacol; 1996 Sep; 50(3):482-92. PubMed ID: 8794885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
